Samantha Lee
Psychiatry · Daphne, ALNPI 1508443102
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 156 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$794
- Alkermes, Inc.$459
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$416
- Otsuka America Pharmaceutical, Inc.$411
- Teva Pharmaceuticals USA, Inc.$253
- Corium, LLC$204
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $794 |
| Alkermes, Inc. | 19 | $459 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $416 |
| Otsuka America Pharmaceutical, Inc. | 20 | $411 |
| Teva Pharmaceuticals USA, Inc. | 11 | $253 |
| Corium, LLC | 12 | $204 |
| Indivior Inc. | 5 | $148 |
| Johnson & Johnson | 6 | $131 |
| E.r. Squibb & Sons, L.L.C. | 2 | $126 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Axsome Therapeutics, Inc. | 5 | $90 |
| Lundbeck LLC | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| Neurocrine Biosciences, Inc. | 3 | $79 |
| Bioventus LLC | 1 | $78 |
| Tris Pharma Inc | 2 | $46 |
| Neos Therapeutics, LP | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$249
- CAPLYTA$125
- ABILIFY ASIMTUFII$125
- ABILIFY MAINTENA$125
How this compares
$3,541 in reported general payments places this provider in the 80th percentile of 400 psychiatry providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 17 | $3,254 |
| Aripiprazole | 31 | $2,528 |
| Ziprasidone Hcl | 18 | $1,697 |
| Bupropion XlBupropion Hcl | 92 | $1,389 |
| Oxcarbazepine | 15 | $1,303 |
| Trazodone Hcl | 124 | $1,100 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $907 |
| Duloxetine Hcl | 48 | $898 |
| Quetiapine Fumarate | 44 | $841 |
| Buspirone Hcl | 55 | $827 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $671 |
| Mirtazapine | 44 | $542 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $520 |
| Olanzapine | 25 | $422 |
| Divalproex Sodium ErDivalproex Sodium | 24 | $419 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Daphne
- Maridith HollisDaphne$17K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
- Scariya KumaramangalamHuntsville$440K
- Mark HaygoodMobile$348K
- Lori DavisTuscaloosa$161K
- Bradley SadlerMobile$124K
- Brandi Rudolph BollingJasper$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.